BioTime Reviews

3.6

81% would recommend to a friend

(5 total reviews)

Michael D. West

81% approve of CEO

87% positive business outlook

Reviews by job title

5 reviews
4.0
10 Oct 2024

Review

Recommend
CEO approval
Business outlook

Pros

Flexible, friendly, continuous, collaborative, consistent

Cons

Not none, none, none, none

5.0
9 May 2024

Good company

Recommend
CEO approval
Business outlook

Pros

Good leadership, great group of people to work with.

Cons

Research groups can be a little fractured .

1.0
22 Dec 2016

Unhealthy Health Industry Employer

Anonymous employee
Recommend
CEO approval
Business outlook

Pros

BioTime successfully transitioned from blood products to stem cell focus at an excellent time, and attracted some strong backers with excellent resources and know-how.

Cons

Internal management is scattered and unfocused. CEO Mike West consistently opts for expenditures based on personal whims and self-glorification rather than overall company well-being. Rewards are rarely based on merit.

Viewing 1 - 3 of 5 Reviews

Glassdoor has 5 BioTime reviews submitted anonymously by BioTime employees. Read employee reviews and ratings on Glassdoor to decide if BioTime is right for you.